AcquisitionOther
BioMarin Pharmaceutical Inc acquired Amicus Therapeutics
Public deal record from 8-K. The source names the buyer and target, and terms are shown only when the filing or announcement discloses them.
Deal tape row
BioMarin Pharmaceutical Inc -> Amicus Therapeutics · $4.8 billion
To acquire marketed, high-growth rare disease products and expand access to Fabry and Pompe disease treatments globally.
Open source record (SEC) ↗